Construction of human ghrelin receptor (hGHS-R1a) model using a fragmental prediction approach and validation through docking analysis

Journal of Medicinal Chemistry

Volumn 49, Issue 11, 2006, Pages 3077-3085

  Pedretti, Alessandro ^a   Villa, Marco ^a   Pallavicini, Marco ^a   Valoti, Ermanno ^a   Vistoli, Giulio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE; HORMONE RECEPTOR; INDAN DERIVATIVE; INDOLE DERIVATIVE; RHODOPSIN; SPIRO COMPOUND; TETRAPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BIOLOGICAL ACTIVITY; CRYSTAL STRUCTURE; ENERGY BALANCE; HORMONE RELEASE; HYDROGEN BOND; HYDROPHOBICITY; MUTAGENESIS; OBESITY; PROTEIN ANALYSIS; PROTEIN FOLDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR UPREGULATION; SEQUENCE HOMOLOGY;

BINDING SITES; HUMANS; MODELS, MOLECULAR; OLIGOPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 33744814084     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm058053k     Document Type: Article

References (54)

1. Korbonits, M., Goldstone, A. P., Gueorguiev, M., Grossman, A. B. Ghrelin -a hormone with multiple functions. Front. Neuroendocrinol. 2004, 25, 27-68.
2. Ghigo, E.; Broglio, F.; Arvat, E.; Maccario, M.; Papotti, M.; Cuccioli, G. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin. Endocrinol. 2005, 62, 1-17.
3. Bowers, C. Y.; Momany, F.; Reynolds, G. A.; Chang, D.; Hong, A.; Chang, K. Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 1980, 106, 663-667.
4. Howard, A. D.; Feighner, S. D.; Cully, D. F.; Arena, J. P.; Liberator, P. L.; Rosemblum, C. I.; Hamelin, M.; Liu, K. K.; Heavens, R.; Rigby, M. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273, 974-977.
5. The complete amino acidic sequence of ghrelin is GSS(octanoil)- FLSPEHQRVQQRKESKKPPAKLQPR.
6. Kojima, M.; Hosoda, H.; Date, Y.; Nakazato, M.; Matsuo, H.; Kangawa, K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402, 656-660.
7. Matsumoto, M.; Hosoda, H.; Morizumi, N.; Hayashi, Y. Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem. Biophys. Res. Commun. 2001, 287, 142-146.
8. Kojima, M.; Kangawa, K. Ghrelin: structure and function. Physiol. Reu. 2005, 85, 495-522.
9. Otto, B.; Spranger, J.; Benoit, S. C.; Clegg, D. J.; Tschop, M. H. The many faces of ghrelin: new perspectives for nutrition research? Br. J. Nutr. 2005, 93, 765-771.
10. Ueno, H.; Yamaguchi, H.; Kangawa, K.; Nakazato, M., Ghrelin: a gastric peptide that regulates food intake and energy homeostasis. Regul. Pept. 2005, 126, 11-19.
11. van der Lely, A. J.; Tschop, M.; Heiman, M. L.; Ghigo, E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 2004, 25, 426-457.
12. Smith, R. G. Development of growth hormone secretagogues. Endocr. Rev. 2005, 26, 346-360.
13. Cummings, D. E.; Foster-Schubert, K. E.; Overduin, Ghrelin and energy balance: focus on current controversies. J. Curr. Drug. Targets 2005, 6, 153-169.
14. Smith, R. G.; Sun, Y.; Betancourt, L.; Asnicar, M. Growth hormone secretagogues: prospects and potential pitfalls. Best Pract. Res., Clin. Endocrinol. Metab. 2004, 18, 333-347.
15. McKee, K. K.; Palyha, O. C.; Feighner, S. D.; Hreniuk, D. L.; Tan, C. P.; Phillips, M. S.; Smith, R. G.; Van der Ploeg, L. H.; Howard, A. D. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol. Endocrinol. 1997, 11, 415-423
16. Smith, R. G.; Leonard, R.; Bailey, A. R. T.; Palyha, O.; Feighner, S.; Tan, C.; McKee, K. K.; Pong, S.-S.; Griffin, P.; Howard, A. Growth hormone secretagogue receptor family members and ligands. Endocrine 2001, 14, 9-14.
17. Holst, B.; Holliday, N. D.; Bach, A.; Elling, C. E.; Cox, H. M.; Schwartz, T. W. Common structural basis for constitutive activity of the ghrelin receptor family. J. Biol. Chem. 2004, 279, 53806-53817.
18. Petersenn, S.; Rasch, A. C.; Penshorn, M.; Beil, F. U.; Schulte, H. M. Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology 2001, 142, 2649-2659.
19. In this article, the residues are progressively numbered from 1 to 366, irrespective of the corresponding segment.
20. Feighner, S. D.; Howard, A. D.; Prendergast, K.; Palyha, O. C.; Hreniuk, D. L.; Nargund, R.; Underwood, D.; Tata, J. R.; Dean, D. C.; Tan, C. P.; McKee, K. K.; Woods, J. W.; Patchett, A. A.; Smith, R. G.; van der Ploeg, L. H. T. Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Mol. Endocrinol. 1998, 12, 137-145.
21. Holst, B.; Cygankiewicz, A.; Jensen, T. H.; Ankersen, M.; Schwartz, T. W. High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Mol. Endocrinol. 2003, 17, 2201-2210.
22. Elling, C. E.; Thirstrup, K.; Holst, B.; Schwartz, T. W. Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 12322-12327.
23. Filipek, S.; Teller, D. C.; Palczewski, K.; Stenkamp, R. The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors. Annu. Rev. Biophys. Biomol. Struct. 2003, 32, 375-397
24. Fanelli, F.; De Benedetti, P. G. Computational modeling approaches to structure-function analysis of G protein-coupled receptors. Chem. Rev. 2005, 105, 3297-3351.
25. Evers, A.; Hessler, G.; Matter, H.; Klabunde, T. Virtual screening of biogenic amine-binding G-protein coupled receptors: Comparative evaluation of protein- and ligand-based virtual screening protocols, J. Med. Chem., 2005, 48, 5448-5465 and references cited herein.
26. Shacham, S.; Topf, M.; Avisar, N.; Glaser, F.; Marantz, Y.; Bar-Haim, S.; Noiman, S.; Naor, Z.; Becker, O. M. Modeling the 3D structure of GPCRs from sequence. Med. Res. Rev. 2001, 21, 472-483.
27. Ginalski, K.; Grishin, N. V.; Godzik, A.; Rychlewski, L. Practical lessons from protein structure prediction. Nucleic Acids Res. 2005, 33, 1874-1891.
28. Fischer, D. 3D-Shotgun: a novel cooperative fold-recognition metapredictor, Proteins, 2003, 51, 434-441.
29. Bednarek, M. A.; Feighner, S. D.; Pong, S. S.; McKee, K. K.; Hreniuk, D. L.; Silva, M. V.; Warren, V. A.; Howard, A. D.; van Der Ploeg, L. H.; Heck, J. V. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 2000, 43, 4370-4376.
30. Riek, R. P.; Rigoutsos, I.; Novotny, J.; Graham, R. M. Nonalphahelical elements modulate polytopic membrane protein architecture. J. Mol. Biol. 2001, 306, 349-362.
31. The average distance between a pair of helices was calculated by averaging the lowest distances obtained considering all possible residues of the second helix for each residue of the first helix. The position of each residue is defined only by the Cα atom.
32. Bondensgaard, K.; Ankersen, M.; Thogersen, H.; Hansen, B. S.; Wulff, B. S.; Bywater, R. P. Recognition of privileged structures by G-protein coupled receptors. J. Med. Chem. 2004, 47, 888-899.
33. Sakmar, T. P.; Menon, S. T.; Marin, E. P.; Awad, E. S. Rhodopsin: insights from recent structural studies. Annu. Rev. Biophys. Biomol. Struct. 2002, 31, 443-484.
34. Pedretti, A.; Silva, M. E.; Villa, L.; Vistoli, G. Binding site analysis of full-length alpha(1a) adrenergic receptor using homology modeling and molecular docking. Biochem. Biophys. Res. Commun. 2004, 310, 1083-1088.
35. Matsuura, B.; Dong, M.; Miller, L. J. Differential determinants for peptide and nonpeptidyl ligand binding to the Motilin receptor. J. Biol. Chem. 2002, 277, 9834-9839.
36. ftp://dasher.wustl.edu/pub/qsar.
37. Holst, B.; Brandt, E.; Bach, A.; Heding, A.; Schwartz, T. W. Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling. Mol. Endocrinol. 2005, 19, 2400-2411.
38. http://www.expasy.org/uniprot/GHSR_HUMAN.
39. http://www.ch.embnet.org/software/TMPRED_form.html.
40. The sequence fragmentation was also performed using other approaches (DAS, KKD, SOSU1, TMHMM, HMMTOP) obtaining results that were quite identical.
41. Shi, J.; Blundell, T. L.; Mizuguchi, K., FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J. Mol. Biol. 2001, 310, 243-257.
42. Karnik, S. S.; Gogonea, C.; Patil, S.; Saad, Y.; Takezako, T. Activation of G-protein-coupled receptors: a common molecular mechanism. Trends. Endocrinol. Metab. 2003, 14, 431-437.
43. Pedretti, A.; Villa, L.; Vistoli, G. VEGA: a versatile program to convert, handle and visualize molecular structure on windows-based PCs. J. Mol. Graphics Modell. 2002, 21, 47-49.
44. Laskowski, R. A.; MacArthur, M. W.; Moss, D. S.; Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283-291.
45. Bowie, J. U.; Luthy, R.; Eisenberg, D. A method to identify protein sequences that fold into a known three-dimensional structure. Science. 1991, 253, 164-170.
46. Kalé, L.; Skeel, R.; Bhandarkar, M.; Brunner, R.; Gursoy, A.; Krawetz, N.; Phillips, J.; Shinozaki, A.; Varadarajan, K.; Schulten. K. NAMD2: Greater scalability for parallel molecular dynamics. J. Comput. Phys. 1999, 151, 283-312.
47. Heiman, M. L.; Nekola, M. V.; Murphy, W. A.; Lance, V. A.; Coy, D. H. An extremely sensitive in vitro model for elucidating structure-activity relationships of growth hormone-releasing factor analogues, Endocrinology 1985, 116, 410-415.
48. Chen, M. H.; Pollard, P. P.; Patchett, A. A.; Cheng, K.; Wei, L.; Chan, W. W.; Butler, B.; Jacks, T. M.; Smith, R. G. Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues. Bioorg. Med. Chem. Lett. 1999, 9, 1261-1266.
49. Carpino, P. A.; Lefker, B. A.; Toler, S. M.; Pan, L. C.; Hadcock, J. R.; Cook, E. R.; DiBrino, J. N.; Campeta, A. M.; DeNinno, S. L.; Chidsey-Frink, K. L.; Hada, W. A.; Inthavongsay, J.; Mangano, F. M.; Mullins, M. A.; Nickerson, D. F.; Ng, O.; Pirie, C. M., Ragan, J. A.; Rose, C. R.; Tess, D. A.; Wright, A. S.; Yu, L.; Zawistoski, M. P.; DaSilva-Jardine, P. A.; Wilson, T. C.; Thompson, D. D. Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin. Bioorg. Med. Chem. 2003, 11, 581-590.
50. Peschke, B.; Ankersen, M.; Hansen, T. K.; Hansen, B. S.; Lau, J.; Nielsen, K. K.; Raun, K. New highly potent dipeptidic growth hormone secretagogues with low molecular weight. Eur. J. Med. Chem. 2000, 35, 599-618.
51. Yang, L.; Morriello, G.; Patchett, A. A.; Leung, K.; Jacks, T.; Cheng, K.; Schleim, K. D.; Feeney, W.; Chan, W. W.; Chiu, S. H.; Smith, R. G., 1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]- 3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163, 540): a potent, orally bioavailable, and short-duration growth hormone secretagogue. J. Med. Chem. 1998, 41, 2439-2441.
52. DeVita, R. J.; Bochis, R.; Frontier, A. J.; Kotliar, A.; Fisher, M. H.; Schoen, W. R.; Wyvratt, M. J.; Cheng, K.; Chan, W. W.; Butler, B.; Jacks, T. M.; Hickey, G. J.; Schleim, K. D.; Leung, K.; Chen, Z.; Chiu, S. L.; Feeney, W. P.; Cunningham, P. K.; Smith, R. G. A potent, orally bioavailable benzazepinone growth hormone secretagogue. J. Med. Chem. 1998, 41, 1716-1728.
53. Huang, P.; Loew, G. H.; Funamizu, H.; Mimura, M.; Ishiyama, N.; Hayashida, M.; Okuno, T.; Shimada, O.; Okuyama, A.; Ikegami, S.; Nakano, J.; Inoguchi, K. Rational design, discovery, and synthesis of a novel series of potent growth hormone secretagogues. J. Med. Chem. 2001, 44, 4082-4091.
54. Rarey, M.; Kramer, B.; Lengauer, T.; Klebe, G. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 1996, 261, 470-489.